Physician

Krishna A Rao, M.D.

According to 2025 Medicare claims, Krishna Rao, M.D. (NPI: 1235128109) practices hematology/oncology in the Springfield, IL market, with the plurality of this provider's patient population coming from Sangamon, IL. This provider's primary affiliated billing organization is SIU PHYSICIANS & SURGEONS, INC (NPI: 1558385989; TIN: 36-4143823) and primary practice location at 62702-4901. Rao is affiliated with the IRCCO (ACO ID: A2619), The Rural Advantage LLC (ACO ID: A5257), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Rao's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 294 traditional Medicare patients, billed 45,469 HCPCS/CPT codes, and received $615,916 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 561 prescription claims across 98 beneficiaries totaling $1,648,745 in drug costs, led by Xtandi (Enzalutamide). 2023 DME data shows 12 claims. Open Payments data shows 22 records totaling $40,164. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $259,930 and ending at $615,916. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $449,444 to $1,648,745. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	201	12,690	$259,930
2016	225	27,372	$468,035
2017	206	28,560	$618,808
2018	322	51,191	$901,688
2019	379	46,971	$719,173
2020	342	17,708	$428,085
2021	364	27,899	$518,577
2022	362	48,033	$906,458
2023	295	31,569	$487,920
2024	294	45,469	$615,916

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	42	259	$449,444
2016	49	276	$762,368
2017	65	410	$850,906
2018	77	454	$918,227
2019	85	455	$973,108
2020	106	544	$1,072,788
2021	92	541	$1,465,766
2022	97	561	$1,443,545
2023	105	651	$1,705,379
2024	98	561	$1,648,745

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	15	$1,842
2018	N/R	14	$1,668
2019	N/R	26	$4,305
2020	N/R	34	$4,839
2021	N/R	21	$3,588
2022	N/R	12	$1,798
2023	N/R	12	$2,169
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	47	86	$140
96413	Administration of chemotherapy into vein, 1 hour or less	38	97	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	76	114	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	91	121	$61
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	30	42	$45

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	23	1,050	$506,768
Lumakras	Sotorasib	11	330	$118,458
Everolimus	Everolimus	27	758	$83,930
Zarxio	Filgrastim-Sndz	27	217	$27,843
Xarelto	Rivaroxaban	14	600	$11,034

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$2,443	F. Hoffmann-La Roche AG
Research Payments	Reported research-related payment or transfer-of-value amount.	13	$37,721	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Krishna A. Rao, M.D.?

Tedicare shows public-source Medicare data for Krishna A. Rao, M.D. (NPI 1235128109), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Krishna A. Rao, M.D. have ACO affiliation data?

Krishna A. Rao, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), The Rural Advantage LLC (MSSP, ACO ID A5257), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Krishna A. Rao, M.D.?

Krishna A. Rao, M.D. is linked to SIU PHYSICIANS & SURGEONS, INC (billing NPI 1558385989) in the available physician profile data.

Does Krishna A. Rao, M.D. have Open Payments data?

Krishna A. Rao, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.